Company Analysis

Immunocore Holdings plc (IMCR)

Nasdaq: IMCR · Biological Products, (No Diagnostic Substances) · Oxfordshire, GB · filing with the SEC since 2016
Grade6.7
◀ Past 7.3● Present 6.6▶ Future 6.1
1 est.

Who runs Immunocore Holdings plc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Jallal Bahija
CHIEF EXECUTIVE OFFICER. First filing Jan 2024, latest Feb 19, 2026, 1 filing in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
20 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Jallal BahijaCHIEF EXECUTIVE OFFICERJan 2024Feb 19, 20261 · $400,000
Coy Travis AlanChief Financial OfficerJan 2024Feb 19, 2026none
St Leger Tina AmberCHIEF HR OFFICERJan 2024Feb 19, 20261 · $0.00
Berman David MHEAD OF R&DJan 2024Feb 19, 20268 · $7.4M
Goll JohnSVP, FINANCE & CAOJan 2024Feb 19, 20261 · $0.00
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bell John IrvingdirectorJan 2024May 28, 2026none
Herbst Roy StevendirectorJan 2024May 28, 2026none
Kaul SiddharthdirectorJan 2024May 28, 2026none
Pao WilliamdirectorFeb 2025May 28, 2026none
Peterson KristinedirectorJan 2024May 28, 2026none
Ratcliffe Peter JohndirectorJan 2024May 28, 2026none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton IMCR · research, not advice